Literature DB >> 15061573

B-cell biology.

Elena Weinstein1, Elena Peeva, Chaim Putterman, Betty Diamond.   

Abstract

In recent years, our understanding of B-cell biology and the roles of B cells in normal immune responses and autoimmunity has increased dramatically. We no longer think of B cells simply as antibody factories. It is clear that these diverse and exquisitely regulated cells may contribute in a multitude of ways to immune responses. Animal models, clinical trials of biologic agents, and the ever expanding field of molecular biology have made great contributions to our current knowledge. With this improved understanding, we are afforded the opportunity to consider numerous potential therapeutic targets for treating autoimmune disease. As this growing science evolves, we can expect to see the advent of new therapies and new hope for patients who are afflicted with these disorders.

Entities:  

Mesh:

Year:  2004        PMID: 15061573     DOI: 10.1016/S0889-857X(03)00109-1

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  5 in total

1.  Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response.

Authors:  Takashi Matsushita; Manabu Fujimoto; Minoru Hasegawa; Kazuhiro Komura; Kazuhiko Takehara; Thomas F Tedder; Shinichi Sato
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

2.  Ligation of human Fc receptor like-2 by monoclonal antibodies down-regulates B-cell receptor-mediated signalling.

Authors:  Mahdi Shabani; Ali Ahmad Bayat; Mahmood Jeddi-Tehrani; Hodjatallah Rabbani; Mohammad Hojjat-Farsangi; Cristina Ulivieri; Zahra Amirghofran; Cosima Tatiana Baldari; Fazel Shokri
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

Review 3.  Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials.

Authors:  Harry Alexopoulos; Angie Biba; Marinos C Dalakas
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 4.  Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases.

Authors:  Panos Stathopoulos; Marinos C Dalakas
Journal:  Neurotherapeutics       Date:  2022-02-18       Impact factor: 6.088

5.  Differential Plasma-cell evolution is linked with Dermatophagoides pteronyssinus immunotherapy response.

Authors:  Tahia D Fernández; Enrique Gómez; Inmaculada Doña; Paloma Campo; Carmen Rondon; Miguel Gonzalez; Francisca Gomez; Francisca Palomares; Maria Salas; Miguel Blanca; Cristobalina Mayorga; Maria J Torres
Journal:  Sci Rep       Date:  2015-09-29       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.